Skip to content
OpenCapital
Get started

LifeStance Health Group LFST Stock-Based Comp

Stock-Based Comp at other companies

CVS Health logo
CVS HealthCVS
$266M+111%
National Healthcare logo
National HealthcareNHC
$1.28M+24.6%
Acadia Healthcare logo
Acadia HealthcareACHC
$7.96M-8.3%
BrightSpring Health Services, Inc. logo
BrightSpring Health Services, Inc.BTSG
$3.68M-76.6%
Universal Health Services logo
Universal Health ServicesUHS
$22.5M+4.2%
Encompass Health Corporation logo
Encompass Health CorporationEHC
$11.5M+21.1%

Other financials

Income statement

See full
Revenue$403.5M+21.2%
Operating income$22.3M+1,289%
Net income$14.2M+1,909%
EPS (diluted)$0.04—

Balance sheet

See full
Cash & equivalents$194.8M+45.0%
Total debt$476.8M-1.1%
Total equity$1.5B+1.4%
Total assets$2.1B+2.0%

Cash flow

See full
Operating cash flow$33.1M+1,171%
CapEx$10.8M+50.2%
Free cash flow$22.3M+318%

Valuation

See full
Market cap$3.6B-4.8%

Profitability

See full
Operating margin3%+2.4pp
Net margin1.6%+1.0pp
FCF margin9.5%+1.6pp

Returns & leverage

See full
Return on equity1.6%+1.0pp
Debt / equity0.3×0.0×
Current ratio1.5×0.0×

Where this comes from

Reported directly by LifeStance Health Group in its filing.

Tagged under the XBRL concept us-gaap:ShareBasedCompensation.

The official record: LifeStance Health Group’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about LifeStance Health Group's stock-based comp.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is LifeStance Health Group's stock-based comp?
LifeStance Health Group (LFST) reported stock-based comp of $15.2M in Q1 2026.
How has LifeStance Health Group's stock-based comp changed year-over-year?
LifeStance Health Group's stock-based comp decreased by 18.2% year-over-year, from $18.58M to $15.2M.
What is the long-term trend for LifeStance Health Group's stock-based comp?
Over 4 years (2021 to 2025), LifeStance Health Group's stock-based comp has grown at a -26.7% compound annual growth rate (CAGR), from $259.44M to $74.7M.
What does stock-based comp mean?
Total non-cash stock-based compensation expense for equity awards (RSUs, options, ESPP), added back to net income in cash flow reconciliation.